featured
Extended Ibrutinib Exposure Prolongs CLL/SLL Remission
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Three-Year Follow-Up Of Treatment-Naïve and Previously Treated Patients With CLL and SLL Receiving Single-Agent Ibrutinib
Blood 2015 Feb 19;[EPub Ahead of Print], JC Byrd, RR Furman, SE Coutre, JA Burger, KA Blum, M Coleman, WG Wierda, JA Jones, W Zhao, NA Heerema, AJ Johnson, Y Shaw, E Bilotti, C Zhou, DF James, S O'BrienFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.